Senator Rick Scott Jumps into the Race to the Bottom on Global Drug Index Pricing

Recently, Sen. Rick Scott (R-FL) introduced S. 977, the “Transparent Drug Pricing Act.” This bill is another attempt to curb prescription drug prices by starting a race to the bottom. S. 977 would prevent pharmaceutical companies from charging a retail price for a drug that is higher than the lowest cost for the same drug found in five other countries: Canada, France, Germany, Japan and the United Kingdom (U.K.). This scheme links drug prices on prices paid in a handful of countries with socialized medicine, where government bureaucrats undervalue and tightly ration access to lifesaving drugs developed here in America. It’s a ridiculous, dangerous idea that flies in the face of the President’s promise to unleash free market forces into the health care industry, and put a stop to decades of exploitation of U.S. intellectual property by foreign governments.

Trade Alliance to Promote Prosperity Urges Opposition to S. 977, the Transparent Drug Pricing Act

Ainsley Shea